We are live on ! Find out more
CGL

Clarius Group LLC Portfolio holdings

AUM $1.75B
1-Year Est. Return 19.04%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+19.04%
3 Year Est. Return
+92.07%
5 Year Est. Return
+98.79%
10 Year Est. Return
+415.93%
AUM
$631M
AUM Growth
+$86.3M
Cap. Flow
+$27.4M
Cap. Flow %
4.34%
Top 10 Hldgs %
54.01%
Holding
309
New
31
Increased
145
Reduced
97
Closed
13

Sector Composition

Rank Sector Weight
1 Industrials 17.98%
2 Technology 16.47%
3 Consumer Discretionary 9.44%
4 Communication Services 5%
5 Financials 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMCB icon
176
iShares Morningstar Mid-Cap ETF
IMCB
$1.65B
$348K 0.06%
6,560
RSG icon
177
Republic Services
RSG
$64.8B
$347K 0.06%
3,745
+140
+4% +$12.2K
IWM icon
178
iShares Russell 2000 ETF
IWM
$79.8B
$345K 0.05%
2,059
+541
+36% +$85.5K
MET icon
179
MetLife
MET
$61.9B
$345K 0.05%
6,653
-20
-0.3% -$965
BSX icon
180
Boston Scientific
BSX
$69.5B
$342K 0.05%
8,044
-1,136
-12% -$47.5K
IVV icon
181
iShares Core S&P 500 ETF
IVV
$878B
$341K 0.05%
1,035
NSC icon
182
Norfolk Southern
NSC
$75.4B
$341K 0.05%
1,681
-440
-21% -$82.5K
GPN icon
183
Global Payments
GPN
$23B
$340K 0.05%
1,751
+140
+9% +$24K
PSX icon
184
Phillips 66
PSX
$84.9B
$340K 0.05%
3,244
+407
+14% +$45.7K
VRTX icon
185
Vertex Pharmaceuticals
VRTX
$121B
$340K 0.05%
1,451
+43
+3% +$8.7K
HSBC icon
186
HSBC
HSBC
$365B
$338K 0.05%
8,811
-215
-2% -$8.15K
AGN
187
DELISTED
Allergan plc
AGN
$338K 0.05%
1,743
+195
+13% +$35.2K
EL icon
188
Estee Lauder
EL
$30.4B
$336K 0.05%
1,537
+121
+9% +$23.5K
OKTA icon
189
Okta
OKTA
$24.7B
$336K 0.05%
2,610
SAP icon
190
SAP
SAP
$212B
$333K 0.05%
2,439
-296
-11% -$38.9K
EMR icon
191
Emerson Electric
EMR
$83.9B
$330K 0.05%
4,310
+489
+13% +$35.2K
KMB icon
192
Kimberly-Clark
KMB
$36.3B
$329K 0.05%
2,312
+118
+5% +$16K
SLB icon
193
SLB Ltd
SLB
$73.6B
$326K 0.05%
8,502
+184
+2% +$6.57K
SPHQ icon
194
Invesco S&P 500 Quality ETF
SPHQ
$19.4B
$323K 0.05%
8,667
VLO icon
195
Valero Energy
VLO
$90.1B
$319K 0.05%
3,454
+200
+6% +$18.9K
EXPD icon
196
Expeditors International
EXPD
$22B
$316K 0.05%
3,989
+277
+7% +$20.8K
AZN icon
197
AstraZeneca
AZN
$263B
$315K 0.05%
3,098
+29
+0.9% +$2.73K
RDS.A
198
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$306K 0.05%
5,208
-1,089
-17% -$63.6K
GSK icon
199
GSK
GSK
$104B
$305K 0.05%
5,123
-7
-0.1% -$389
SHW icon
200
Sherwin-Williams
SHW
$82.7B
$299K 0.05%
1,536
+114
+8% +$21.7K

Similar funds

Clarius Group LLC's Q4 2019 Portfolio in Review

As of Q4 2019, Clarius Group LLC held 309 positions worth $631M, up 16% from $545M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Clarius Group LLC deployed $27.4M of net new capital in Q4 2019, opening 31 new positions and adding to 145 existing holdings. Its largest new stake was Sage Therapeutics: 35,500 shares worth $2.66M.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Microsoft, an estimated $11.8M trimmed.

  • Clarius Group LLC's largest Q4 2019 buy was Sage Therapeutics: 35,500 shares worth $2.66M.
  • Clarius Group LLC added most to Invesco Russell 1000 Dynamic Multifactor ETF in Q4 2019, an estimated $7.61M increase.
  • Clarius Group LLC's biggest Q4 2019 reduction was Microsoft, cutting an estimated $11.8M.
  • Clarius Group LLC fully exited Berkshire Hathaway Class A in Q4 2019, selling an estimated $2.18M.
  • Clarius Group LLC's ten largest holdings make up 54% of its $631M portfolio in Q4 2019.
  • Clarius Group LLC opened 31 new positions and closed 13 in Q4 2019.
  • Clarius Group LLC's portfolio value rose 16% quarter-over-quarter to $631M.

Based on Clarius Group LLC's 13F filing for Q4 2019, filed 22 Jan 2020.